is a global IT consulting and managed services provider that focuses on the life sciences industry. We have extensive experience in the implementation, integration, migration, upgrade, and hosting of the following Oracle clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, and electronic data capture systems: Siebel Clinical, LabPas, Argus Safety Suite (Argus Safety, Argus Safety Japan, Affiliate, Interchange, Reconciliation, Dossier, Insight, and Perceptive), Adverse Event Reporting System (AERS), Empirica Signal, Empirica Topics, Life Sciences Data Hub (LSH), Clinical Development Analytics (CDA), Oracle Clinical, Remote Data Capture (RDC), and Thesaurus Management System (TMS).
Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company's products and services, please call +1 877 654 0033 (U.S.), +44 (0) 1865 910200 (U.K.), or e-mail info(at)biopharm(dot)com.
Oracle and Java are registered trademarks of Oracle and/or its affiliates.
North America Sales Contact:
+1 877 654 0033
Europe/Middle East/Africa Sales Contact:
+44 (0) 1865 910200
+1 617 795 2032
Google Plus: plus.google.com/104105608638786200757
Read the full story at http://www.prweb.com/releases/oracle-clinical-rdc-trial/software/prweb10208755.htm.
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. BioPharm Systems to Host Webinar on Self-service Account Management for Oracle Clinical, Remote Data Capture, and Thesaurus Management System2
. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting3
. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer4
. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option5
. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer6
. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference7
. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results8
. John A. Orwin Joins Array BioPharma Board Of Directors9
. Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor10
. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm11
. Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts